Showing results (571-580 of 3,079) with videos related to

Sort By:
Pageof 308
Drug Safety|November 2, 2014
A cross-country comparison of rivaroxaban spontaneous adverse event reports and concomitant medicine use with the potential to increase the risk of harmCameron J McDonald, Lisa M Kalisch Ellett, John D Barratt, et al.
Drug Safety|January 16, 2020
Developing Predictive Models to Determine Patients in End-of-Life Care in Administrative DatasetsJoel N Swerdel, Jenna M Reps, Daniel Fife, et al.
Drug Safety|November 11, 2020
Real-World Data on Nonmedical Use of Tramadol from Patients Evaluated for Substance Abuse Treatment in the NAVIPPRO Addiction Severity Index-Multimedia Version (ASI-MV®) NetworkJody L Green, Taryn Dailey-Govoni, Stephen F Butler
Drug Safety|November 12, 2020
Efficacy and Safety of Bevacizumab Plus Oxaliplatin- or Irinotecan-Based Doublet Backbone Chemotherapy as the First-Line Treatment of Metastatic Colorectal Cancer: A Systematic Review and Meta-analysisTianshu Ren, Shu Wang, Zexu Shen, et al.
Drug Safety|February 9, 2020
Benzodiazepine Use and Risk of Acute Angle-Closure Glaucoma: A Population-Based Case-Crossover StudyWoo Jung Kim, Junqing Li, In-Sun Oh, et al.
Drug Safety|August 16, 2017
Deaths from Medicines: A Systematic Analysis of Coroners' Reports to Prevent Future DeathsRobin E Ferner, Craig Easton, Anthony R Cox
Drug Safety|February 9, 2019
Use of FDA's Sentinel System to Quantify Seizure Risk Immediately Following New Ranolazine ExposureEfe Eworuke, Emily C Welch, Anne Tobenkin, et al.
Drug Safety|October 29, 2017
Correction to: Safety Concerns with HPV Vaccines Continue to Linger: Are Current Vaccine Pharmacovigilance Practices Sufficient?Rebecca E Chandler
Drug Safety|February 8, 2018
A Multi-hospital Before-After Observational Study Using a Point-Prevalence Approach with an Infusion Safety Intervention Bundle to Reduce Intravenous Medication Administration ErrorsKumiko O Schnock, Patricia C Dykes, Jennifer Albert, et al.
Drug Safety|May 17, 2022
Using Iterative Pairwise External Validation to Contextualize Prediction Model Performance: A Use Case Predicting 1-Year Heart Failure Risk in Patients with Diabetes Across Five Data SourcesRoss D Williams, Jenna M Reps, Jan A Kors, et al.
Pageof 308